WO1994004185A3 - Procede pour inhiber la reduction de ponts disulfure - Google Patents

Procede pour inhiber la reduction de ponts disulfure Download PDF

Info

Publication number
WO1994004185A3
WO1994004185A3 PCT/US1993/007805 US9307805W WO9404185A3 WO 1994004185 A3 WO1994004185 A3 WO 1994004185A3 US 9307805 W US9307805 W US 9307805W WO 9404185 A3 WO9404185 A3 WO 9404185A3
Authority
WO
WIPO (PCT)
Prior art keywords
disulfide bonds
inhibiting
membrane
useful
macromolecules
Prior art date
Application number
PCT/US1993/007805
Other languages
English (en)
Other versions
WO1994004185A2 (fr
Inventor
Hughes J-P Ryser
Original Assignee
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Boston filed Critical Univ Boston
Priority to EP93920204A priority Critical patent/EP0656787A1/fr
Publication of WO1994004185A2 publication Critical patent/WO1994004185A2/fr
Publication of WO1994004185A3 publication Critical patent/WO1994004185A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un procécé pour modifier (inhiber ou stimuler), directement ou indirectement, la réduction des ponts disulfure de macromolecules à liaison membranaire, notamment des protéines, et, par suite, inhiber (totalement ou partiellement) ou stimuler la pénétration cellulaire et les effets respectifs de ces macromolécules. Plus particulièrement, la présente invention concerne un procédé pour inhiber, directement ou indirectement, la fonction réductive des membranes cellulaires, notamment la membrane cellulaire de surface (plasma) qui est susceptible de cliver, dans des protéines à liaison membranaire, des ponts disulfure qui doivent être clivés pour que les protéines pénètrent dans les cellules et y produisent leurs effets respectifs. Le clivage des ponts disulfure ainsi réalisé est une étape métabolique nécessaire à la fonction ultime de la protéine ou de la macromolécule. Selon la présente description, le déposant a démontré que la fonction réductive des membranes cellulaires de surface est catalysée par la disulfure-isomérase protéique. Le procédé décrit est utile pour prévenir les effets néfastes des toxines, telles que la toxine diphtérique, sur les cellules. Il est également utile pour prévenir l'infection (virale ou bactérienne) ou la propagation d'une infection établie. Ce procédé peut d'autre part être utile pour stimuler la fixation de macromolécules dont la présence au sein d'une cellule est souhaitée.
PCT/US1993/007805 1992-08-19 1993-08-18 Procede pour inhiber la reduction de ponts disulfure WO1994004185A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP93920204A EP0656787A1 (fr) 1992-08-19 1993-08-18 Procede pour inhiber la reduction de ponts disulfure

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93236992A 1992-08-19 1992-08-19
US07/932,369 1992-08-19
US5219493A 1993-04-22 1993-04-22
US08/052,194 1993-04-22

Publications (2)

Publication Number Publication Date
WO1994004185A2 WO1994004185A2 (fr) 1994-03-03
WO1994004185A3 true WO1994004185A3 (fr) 2004-04-29

Family

ID=26730314

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/007805 WO1994004185A2 (fr) 1992-08-19 1993-08-18 Procede pour inhiber la reduction de ponts disulfure

Country Status (2)

Country Link
EP (1) EP0656787A1 (fr)
WO (1) WO1994004185A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
CA2173964A1 (fr) * 1993-10-15 1995-04-20 Jess G. Thoene Prevention de l'infection par le vih
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
US5532154A (en) * 1994-03-21 1996-07-02 Research Development Foundation Mutated alpha virus
US6977142B2 (en) * 2003-09-23 2005-12-20 Agy Therapeutics, Inc. High-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity
PL227562B1 (pl) 2011-09-23 2017-12-29 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Zastosowanie antybiotyku bacytracyny do hydrolitycznej degradacji RNA

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CHIACCHIA, K.B.: "REOXIDATION OF THE CLASS I DISULFIDES OF THE RAT ADIPOCYTE INSULIN RECEPTOR IS DEPENDENT UPON THE PRESCENCE OF INSULIN: THE CLASS I DISULFIDE OF THE INSULIN RECEPTOR IS EXTRACELLULAR", BIOCHEMISTRY, vol. 27, no. 13, 28 June 1988 (1988-06-28), pages 4894 - 4902 *
FEENER, E.P. ET AL: "CLEAVAGE OF DISULFIDE BONDS IN ENDOCYTOSED MACROMOLECULES", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 31, 5 November 1990 (1990-11-05), pages 18780 - 18785 *
FEENER, EDWARD P.: "THE ROLE OF THE PLASMA MEMBRANE AND A NON-LYSOSOMAL COMPARTMENT IN THE DISULFIDE CLEAVAGE OF ENDOCYTOSED MACROMOLECULES", DISSERTATION ABSTRACTS INTERNATIONAL B, vol. 51, no. 1, July 1990 (1990-07-01), pages 182B *
GIDWITZ, S. ET AL: "DIFFERENCES IN VIRION STABILITY AMONG SINDBIS VIRUS PATHOGENESIS MUTANTS", VIRUS RESEARCH, vol. 10, no. 2,3, 1988, pages 225 - 240 *
LASKY, L.A. ET AL: "DELINEATION OF A REGION OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 GP120 GLYCOPROTEIN CRITICAL FOR INTERACTION WITH THE CD4 RECEPTOR", CELL, vol. 50, 1987, pages 975 - 985 *
MANDEL, R. ET AL: "INHIBITION OF A REDUCTIVE FUNCTION OF THE PLASMA MEMBRANE BY BACITRACIN AND ANTIBODIES AGAINST PROTEIN DISULFIDE-ISOMERASE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 90, no. 9, 1 May 1993 (1993-05-01), pages 4112 - 4116 *
MEYER, W.J. ET AL: "CONFORMATIONAL ALTERATION OF SINDBIS VIRION GLYCOPROTEINS INDUCED BY HEAT, REDUCING AGENTS OR LOW PH", JOURNAL OF VIROLOGY, vol. 66, no. 6, June 1992 (1992-06-01), pages 3504 - 3513 *
RYSER, H. J.-P. ET AL: "CELL SURFACE SULFHYDRYLS ARE REQUIRED FOR THE TOXICITY OF DIPHTHERIA TOXIN BUT NOT OF RICIN IN CHINESE HAMSTER OVARY CELLS", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 28, 5 October 1991 (1991-10-05), pages 18439 - 18442 *
SHEN, W-C. ET AL: "DISULFIDE AND OTHER SPACERS FOR THE INTRACELLULAR RELEASE OF DRUGS FROM POLYMERIC CARRIERS", POLYMER PREPRINTS, vol. 27, no. 1, April 1986 (1986-04-01), pages 9 - 10 *
YOSHIMORI, T. ET AL: "PROTEIN DISULFIDE-ISOMERASE IN RAT EXOCRINE PANCREATIC CELLS IS EXPORTED FROM THE ENDOPLASMIC RETICULUM DESPITE POSSESSING THE RETENTION SIGNAL", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 26, 15 September 1990 (1990-09-15), pages 15984 - 90 *

Also Published As

Publication number Publication date
EP0656787A4 (fr) 1994-04-15
WO1994004185A2 (fr) 1994-03-03
EP0656787A1 (fr) 1995-06-14

Similar Documents

Publication Publication Date Title
DE60011390D1 (de) Verfahren und vorrichtung zur identifikation oder karakterisierung von polypeptiden
DK1283265T3 (da) Fremgangsmåde til fremstilling af protein med reduktion af mannosephosphat i sukkerkæden og glycoprotein fremstillet derved
AU7121494A (en) Separation of proteins
AU1806795A (en) A method of preparing a variant of a lipolytic enzyme
WO1994018332A3 (fr) Proteines de fusion de la toxine du bacille du charbon et leurs utilisations
DK383189A (da) Fremgangsmaade til mikrobiologisk fremstilling af humant serum albumin og lignende heterologe proteiner ved hjaelp af gaer
WO2011012726A3 (fr) Procédé de purification de l'adamts 13 recombinant et d'autres protéines et compositions de ceux-ci
WO1994004185A3 (fr) Procede pour inhiber la reduction de ponts disulfure
WO2002076205A3 (fr) Compositions et procedes de detoxication de zearalenone
AU4626596A (en) Process for preparing macrophages, and kits and compositions therefore
WO1998009990A8 (fr) Antigenes fongiques et processus de fabrication
AU2003213580A1 (en) Subtilisin carlsberg proteins with reduced immunogenicity
EP0359201A3 (fr) Procédé pour stabiliser des facteurs de coagulation sanguine
WO2002012899A3 (fr) Peptides presents par cellules
NO176807C (no) Sammensmeltet gen som koder for et hybridprotein, samt fremgangsmåte for fremstilling av et hybridprotein som kodes av et sammensmeltet gen; vektor og sammensmeltet gen
EP0821064A3 (fr) Fructosyl amino acide oxidase recombinante
AU3307797A (en) A method for increasing hemoprotein production in filamentous fungi
IL127297A0 (en) Spruce budworm antifreeze proteins genes and methods of using same
AU3257197A (en) Process for the activation of denatured protein
AU2363301A (en) Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes
EP0410005A4 (en) Method for crystallizing amino acid
Hunter et al. The role of cytochrome c 4 in bacterial respiration. Cellular location and selective removal from membranes
WO1995013386A3 (fr) Enzyme de fusion de la proteine activatrice de la tyrosinase
AU5704100A (en) Process for producing optically active pyridineethanol derivatives
MX9304691A (es) Metodo para fabricar la toxina de bacillus en levadura metilotrofica y la toxina asi producida.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1993920204

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993920204

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993920204

Country of ref document: EP